Access to Aminated Quaternary Centers by Hyperbaric Aza-Michael Additions
Typical Procedure for the Aza-Michael Reaction of Sulfone 12 with
Amines: A mixture of amine (1.2 mmol), and 12 (1.0 mmol) in
MeOH (1.5 mL) was placed in a Teflon reaction vessel, and the
mixture was pressurized to 8 kbar at room temperature for 48 h.
After the pressure was released, the mixture was concentrated in
vacuo. The crude product was purified by column chromatography
(silica gel, hexane/EtOAc).
4 H), 2.84 (quint., J = 6.7 Hz, 1 H), 3.02 (d, J = 6.8 Hz, 2 H),
3.55–3.65 (m, 4 H), 3.59 (s, 3 H), 5.40 (dd, J = 7.8, 15.4 Hz, 1 H),
1
5.56 (dt, J = 6.8, 15.4 Hz, 1 H) ppm. H NMR (300 MHz, CDCl3,
minor isomer): δ = 1.04 (d, J = 6.7 Hz, 3 H), 2.35–2.50 (m, 4 H),
2.84 (quint., J = 6.7 Hz, 1 H), 3.02 (d, J = 6.8 Hz, 2 H), 3.55–3.65
(m, 4 H), 3.59 (s, 3 H), 5.40 (dd, J = 7.8, 15.4 Hz, 1 H), 5.56 (dt,
J = 6.8, 15.4 Hz, 1 H) ppm. 13C NMR (75 MHz, CDCl3, major
isomer): δ = 17.43 (CH3CH), 37.55 (CH2CO), 50.48 (NCH2), 51.90
(OMe), 62.39 (CHCH3), 67.14 (OCH2), 123.64 (CH=), 136.12
(CH=), 172.17 (C=O) ppm. 13C NMR (75 MHz, CDCl3, minor
isomer): δ = 18.09 (CH3CH), 33.10 (CH2CO), 50.85 (NCH2), 51.84
(OMe), 57.34 (CHCH3), 67.21 (OCH2), 122.39 (CH=), 135.34
Typical Procedure for the Treatment of Ester 1 with Amines: A solu-
tion of the ester (1 mmol) and amine (1 mmol) in THF (1–1.5 mL)
was allowed to stand under 10–16 kbar of pressure at room tem-
perature. After reversion to atmospheric pressure, the solvent was
evaporated. The residue was purified by chromatography (silica gel;
CH2Cl2/MeOH, 9:1; Et2O/pentane, 1:3) to yield the corresponding
products. The following compounds were prepared according to
this procedure.
(CH=), 171.89 (C=O) ppm. IR: ν = 1653 (C=C), 1741 (C=O) cm–1.
˜
MS (IE): m/z (%) = 213 (13) [M]+, 198 (100). C11H19NO3 (213.28):
calcd. C 61.95, H 8.98, N 6.57; found C 61.68, H 9.11, N 6.65.
Methyl 5-Morpholin-4-ylhex-2-enoate (5b): 1H NMR (300 MHz,
CDCl3): δ = 0.96 (d, J = 6.6 Hz, 3 H), 2.12 (ddt, J = 1.4, 8.0,
14.3 Hz, 1 H), 2.35–2.50 (m, 5 H), 2.63 (quint., J = 6.6 Hz, 1 H),
3.55–3.65 (m, 4 H), 3.67 (s, 3 H), 5.79 (dt, J = 1.4, 14.3 Hz, 1 H),
6.91 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 14.93 (CH3),
36.05 (CH2), 49.02 (NCH2), 51.60 (OMe), 58.89 (CH), 67.44
Methyl 3-Morpholin-4-ylbutanoate (2a): 1H NMR (300 MHz,
CDCl3): δ = 1.00 (d, J = 6.6 Hz, 3 H), 2.19 (dd, J = 7.9, 14.3 Hz,
1 H), 2.40–2.55 (m, 5 H), 3.00–3.10 (m, 1 H), 3.55–3.65 (m, 7 H)
ppm. 13C NMR (75 MHz, CDCl3): δ = 14.69 (CH3CH), 38.12
(CH2), 48.61 (NCH2), 51.48 (OCH3), 56.62 (C-N), 67.27 (OCH2),
172.83 (C=O) ppm. IR: ν = 1738 (C=O) cm–1. MS (IE): m/z (%) =
˜
187 (8) [M]+, 172 (11), 114 (100). C9H17NO3 (187.24): calcd. C
57.73, H 9.15, N 7.48; found C 57.32, H 9.23, N 7.76.
2
(OCH ), 122.33 (CH=), 147.56 (CH=), 167.06 (C=O) ppm. IR: ν
˜
= 1656 (C=C), 1723 (C=O) cm–1. MS (IE): m/z (%) = 213 (2)
[M]+, 185 (4), 140 (25), 114 (100). C11H19NO3 (213.28): calcd. C
61.95, H 8.98, N 6.57; found C 61.72, H 9.09, N 6.61.
Methyl 3-Morpholin-4-ylphenylpropanoate (2b): 1H NMR
(300 MHz, CDCl3): δ = 2.35–2.45 (m, 4 H), 2.67 (dd, J = 7.4,
14.9 Hz, 1 H), 3.01 (m, 1 H), 3.60 (s, 3 H), 3.65–3.75 (m, 4 H), 3.92
(t, J = 7.5 Hz, 1 H), 7.25–7.35 (m, 5 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 38.05 (CH2), 50.39 (NCH2), 51.60 (OCH3), 66.25
(CHN), 67.18 (OCH2), 127.63, 128.23, 128.29, 138.56 (Ph), 172.12
Methyl 3-Methyl-3-morpholin-4-ylbutanoate (7a): 1H NMR
(300 MHz, CDCl3): δ = 1.12 (s, 6 H), 2.37 (s, 2 H), 2.45–2.60 (m,
4 H), 3.55–3.70 (m, 7 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
24.11 (CH3), 43.32 (CH2), 46.25 (NCH2), 51.37 (OCH3), 56.21 (C-
(C=O) ppm. IR: ν = 1738 (C=O) cm–1. MS (IE): m/z (%) = 249
˜
N), 67.81 (OCH ), 172.37 (C=O) ppm. IR: ν = 1734 (C=O) cm–1.
˜
2
(7) [M]+, 176 (100). C14H19NO3 (249.31): calcd. C 67.45, H 7.68,
N 5.62; found C 67.45, H 7.66, N 5.60.
MS (IE): m/z (%) = 201 (3) [M]+, 186 (20), 128 (100). C10H19NO3
(201.27): calcd. C 59.68, H 9.52, N 6.96; found C 59.32, H 9.62, N
7.04.
Methyl 2-Methyl-3-morpholin-4-ylpentanoate (2c): 1H NMR
(300 MHz, CDCl3, major diastereomer): δ = 0.89 (t, J = 7.4 Hz, 3
H), 1.15 (d, J = 6.8 Hz, 3 H), 1.20–1.35 (m, 1 H), 1.50–1.60 (m, 1
Methyl 3-Methyl-3-piperidin-4-ylbutanoate (7b): 1H NMR
(300 MHz, CDCl3): δ = 1.08 (s, 6 H), 1.25–1.35 (m, 2 H), 1.35–
1.50 5 (m, 4 H), 2.32 (s, 2 H), 2.35–2.50 (m, 4 H), 3.55 (s, 3 H)
ppm. 13C NMR (75 MHz, CDCl3): δ = 24.78 (CH3), 24.85, 26.90
(CH2 piperidine), 42.70 (CH2), 46.80 (NCH2), 51.27 (OCH3), 56.54
1
H), 2.55–2.65 (m, 6 H), 3.55–3.60 (m, 4 H), 3.63 (s, 3 H) ppm. H
NMR (300 MHz, CDCl3, minor diastereomer): δ = 0.88 (t, J =
7.4 Hz, 3 H), 1.00 (d, J = 6.6 Hz, 3 H), 1.15–1.25 (m, 1 H), 1.30–
1.60 (m, 1 H), 2.40–2.65 (m, 6 H), 3.45–3.50 (m, 4 H), 3.56 (s, 3
H) ppm. 13C NMR (75 MHz, CDCl3, major diastereomer): δ =
12.86 (CH3CH2), 15.32 (CH3CH), 21.72 (CH2CH3), 42.89
(CHCH3), 49.85 (NCH2), 51.64 (OCH3), 67.91 (OCH2), 68.25
(CHN), 176.83 (C=O) ppm. 13C NMR (75 MHz, CDCl3, minor
(C-N), 172.93 (C=O) ppm. IR: ν = 1738 (C=O) cm–1. MS (IE):
˜
m/z (%) = 199 (8) [M]+, 184 (60), 126 (100). C11H21NO2 (199.29):
calcd. C 66.29, H 10.62, N 7.03; found C 66.65, H 10.87, N 7.10.
Ethyl 3-(Dimethylamino)-3-methylbutanoate (7c): 1H NMR
(300 MHz, CDCl3): δ = 1.13 (s, 6 H), 1.20 (t, J = 7.1 Hz, 3 H),
2.20 (s, 6 H), 2.32 (s, 2 H), 4.06 (q, J = 7.1 Hz, 2 H) ppm. 13C
NMR (75 MHz, CDCl3): δ = 14.35 (CH3CH2), 24.41 (CH3C),
38.63 (CH3N), 41.69 (CH2), 56.14 (C-N), 60.22 (OCH2), 172.48
diastereomer):
δ = 13.15 (CH3CH2), 14.80 (CH3CH), 20.67
(CH2CH3), 43.50 (CHCH3), 49.52 (NCH2), 51.25 (OCH3), 67.90
(OCH ), 68.95 (CHN), 176.59 (C=O) ppm. IR: ν = 1737 (C=O)
˜
2
cm–1. MS (IE): m/z (%) = 215 (1) [M]+, 186 (8), 128 (100).
C11H21NO3 (215.29): calcd. C 61.37, H 9.83, N 6.51; found C
61.23, H 10.14, N 6.28.
(C=O) ppm. IR: ν = 1732 (C=O) cm–1. MS (IE): m/z (%) = 173
˜
(5) [M]+, 158 (14), 86 (100). C9H19NO2 (173.25): calcd. C 62.39, H
11.05, N 8.08; found C 62.13, H 11.14, N 8.14.
Ethyl 5-Morpholin-4-ylhex-3-enoate (4a): 1H NMR (300 MHz,
CDCl3): δ = 1.12 (d, J = 6.7 Hz, 3 H), 1.22 (t, J = 7.2 Hz, 3 H),
2.35–2.55 (m, 4 H), 2.84 (quint., J = 6.7 Hz, 1 H), 3.02 (d, J =
6.8 Hz, 2 H), 3.60–3.75 (m, 4 H), 4.10 (q, J = 7.2 Hz, 2 H), 5.45
(dd, J = 7.8, 15.4 Hz, 1 H), 5.62 (dt, J = 6.8, 15.4 Hz, 1 H) ppm.
Ethyl 3-(Diethylamino)-3-methylbutanoate (7d): 1H NMR
(300 MHz, CDCl3): δ = 1.01 (t, J = 7.1 Hz, 6 H), 1.20 (s, 6 H),
1.25 (t, J = 7.2 Hz, 3 H), 2.39 (s, 2 H), 2.54 (q, J = 7.1 Hz, 4 H),
4.10 (q, J = 7.2 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
14.42 (CH3CH2O), 16.84 (CH3CH2N), 26.30 (CH3), 43.76 (CH2),
43.19 (NCH2), 57.63 (C-N), 60.16 (OCH2), 172.64 (C=O) ppm. IR:
13C NMR (75 MHz, CDCl3):
δ = 14.35 (CH3CH2), 17.61
(CH3CH), 37.97 (CH2CO), 50.62 (NCH2), 60.83 (CH2CH3), 62.60
(CHCH3), 67.33 (OCH2), 124.04 (CH=), 136.07 (CH=), 171.95
ν = 1731 (C=O) cm–1. MS (IE): m/z (%) = 201 (4) [M]+, 186 (20),
˜
(C=O) ppm. IR: ν = 1651 (C=C), 1735 (C=O) cm–1. MS (IE): m/z
114 (100). C11H23NO2 (201.31): calcd. C 65.63, H 11.52, N 6.96;
found C 65.78, H 11.56, N 7.18.
˜
(%) = 227 (17) [M]+, 212 (50), 114 (100). C10H19NO3 (201.27):
calcd. C 63.41, H 9.31, N 6.16; found C 63.16, H 9.26, N 6.04.
Methyl
3-{[2-(Dimethylamino)ethyl](methyl)amino}-3-methylbut-
Methyl 5-Morpholin-4-ylhex-3-enoate (4b): 1H NMR (300 MHz,
CDCl3, major isomer): δ = 1.06 (d, J = 6.7 Hz, 3 H), 2.35–2.50 (m,
anoate (7f): 1H NMR (300 MHz, CDCl3): δ = 1.15 (s, 6 H), 2.20
(s, 3 H), 2.23 (s, 6 H), 2.35–2.55 (m, 6 H), 3.62 (s, 3 H) ppm. 13C
Eur. J. Org. Chem. 2010, 6423–6429
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
6427